| # | Drug | Count |
|---|---|---|
| 0 | FLUDARABINE PHOSPHATE | 7 |
| 1 | TREOSULFAN | 7 |
| 2 | ABATACEPT | 6 |
| 3 | RITUXIMAB | 6 |
| 4 | THIOTEPA | 6 |
| 5 | TOCILIZUMAB | 6 |
| 6 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 5 |
| 7 | METHOTREXATE | 2 |
| 8 | METHOTREXATE SODIUM | 2 |
| 9 | ADALIMUMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TREOSULFAN | 7 | 0.0025 |
| 1 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 5 | 0.0006 |
| 2 | THIOTEPA | 6 | 0.0006 |
| 3 | FLUDARABINE PHOSPHATE | 7 | 0.0002 |
| 4 | TOCILIZUMAB | 6 | 0.0001 |
| 5 | ALEMTUZUMAB | 1 | 0.0001 |
| 6 | ABATACEPT | 6 | 0.0000 |
| 7 | RITUXIMAB | 6 | 0.0000 |
| 8 | ADALIMUMAB-FKJP | 1 | 0.0000 |
| 9 | ADALIMUMAB-AATY | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 1 | Interleukin-6 Receptor Antagonist [EPC] | 6 | 0.0000 |
| 2 | Selective T Cell Costimulation Modulator [EPC] | 6 | 0.0000 |
| 3 | Alkylating Drug [EPC] | 6 | 0.0000 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 6 | 0.0000 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 1 | 0.0000 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |